NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer’s clinical syndrome: the ATHENEA randomized clinical trial

Saily Sosa, Giosmany Bringas, Nelky Urrutia, Ana Ibis Peñalver, Danay López, Evelio González Dalmau, Ana Fernández, Zenaida Milagros Hernández, Ariel Vina-Rodrı́guez, Yamilé Peña,

Alzheimer s Research & Therapy · 2023 · 15 citations · 32 references

DOIFull text

Open access

References

32